The NOMADMUS cohort study provides insights into the evolving landscape of AQP4+ neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) from 2010 to 2024. This research highlights trends and changes in patient demographics and disease characteristics over the years.
french nomadmus cohort overview landscape evolution of aqp4 nmosd and mogad from 2010 to 2024
Original title: “French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.”